High Purity Low Endotoxin Recombinant VEGF CAS No. 127464-60-2

High purity low endotoxin recombinant VEGF

Description

Vascular endothelial growth factor(VEGF), also known as vascular permeability factor (VPF), is a highly specific vascular endothelial growth factor that stimulates vascular permeability increasing and cell external matrix degeneration, vascular endothelial cell migration, proliferation and vascularization. VEGF has also been shown to have chemotaxis on monocytes and osteoblasts.

OsrhVEGF, recombinant vascular endothelial growth factor, expressed in the rice endosperm platform and purified by chromatography, is animal component free and has high biological activity. The rice endosperm platform makes the manufacture capability at hundreds of gram scales to meet your bulk bioprocessing needs.

Product Information

Source: Rice Grain (Oryza Sativa)

Appearance: White lyophilized powder

Molecular weight: 19.2 kDa

Purity: ≥95.0% by SDS-PAGE

Activity: ≥ 1×10⁵ IU/mg by a cell proliferation assay using human umbilical vein endothelial cell (HUVEC)

Endotoxin: <0.1 EU/μg

Reconstitution: Recommend to reconstitute OsrhVEGF at 100-200μg/ml in sterile water or PBS. Further dilutions can be made in other aqueous buffer.

Storage: Stored at temperature -20°C for at least 24 months

Healthgen Biotech has strong technical force and advanced and complete protein expression and purification technology development and large-scale production facilities. Self-developed rice endosperm cell expression platform (Oryz^HiExp), which is domestic initiative and the international leader, has such advantages: high expression level, safety, scale-up easily, simple production process and environmental protection etc. After 10 years of unremitting efforts, Healthgen Biotech has established recombinant protein expression and purification technology platform to customize recombinant protein or peptide expression and purification process service for pharmaceuticals, health products, scientific research and industrial reagents. Using the Oryz^HiExp platform, Healthgen Biotech has achievements in developing and commercializing a series of medium ingredients, including recombinant human serum albumin (OsrHSA), recombinant human alphar-1 antitrypsin (OsrhAAT), recombinant human lactoferrin (OsrhLF), recombinant human basic fibroblast growth factor (OsrhbFGF), recombinant human insulin-like growth factor-1 LR3 (rhIGF-1 LR3) and recombinant human epidermal growth factor (rhEGF), which can provide a full set of solutions for animal component free .